Advertisement

Hormones

, Volume 12, Issue 1, pp 19–29 | Cite as

An overview of the pathogenesis of thyroid autoimmunity

  • Giulia Cogni
  • Luca Chiovato
Review

Conclusions

Over half a century has elapsed since the 1956 identification of thyroglobulin antibodies and the devising of the first experimental model of autoimmune thyroiditis. Since then, an incredible amount of experimental work has led to an ever deeper understanding of the nature of thyroid auto-antigens, the main immune mechanisms responsible for Hashimoto’s thyroiditis and Graves’ disease, their genetics, and their environmental risk factors. Yet, in the majority of genetically predisposed people the individual trigger of thyroid autoimmunity remains obscure. Similarly, effective prevention strategies still remain to be established and, hopefully, will be the target of future studies.

Key words

Autoimmunity Environment and thyroid autoimmunity Experimental autoimmune thyroiditis Genes of thyroid autoimmunity Graves’ disease Hashimoto’s thyroiditis Thyroid Thyroid antibodies 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stathatos N, Daniels GH, 2012 Autoimmune thyroid disease. Curr Opin Rheumatol 24: 70–75.CrossRefPubMedGoogle Scholar
  2. 2.
    Rose NR, Bona C, 1993 Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 14: 426–430.CrossRefPubMedGoogle Scholar
  3. 3.
    Weetman AP, 2003 The mechanisms of autoimmunity in endocrinology: application to the thyroid gland. Ann Endocrinol (Paris) 64: 26–27.Google Scholar
  4. 4.
    Tonacchera M, Agretti P, Ceccarini G, et al, 2001 Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. Eur J Endocrinol 144: 611–618.CrossRefPubMedGoogle Scholar
  5. 5.
    Yoshida A, Hisatome I, Taniguchi S, et al, 2009 Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases. J Clin Endocrinol Metab 94: 442–448.CrossRefPubMedGoogle Scholar
  6. 6.
    Ganesh BB, Bhattacharya P, Gopisetty A, Prabhakar BS, 2011 Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity. J Interferon Cytokine Res 31: 721–731.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Vasu C, Dogan RN, Holterman MJ, Prabhakar BS, 2003 Selective induction of dendritic cells using granulocyte macrophagecolony stimulating factor, but not fms-like tyrosine kinase receptor 3-ligand, activates thyroglobulin-specific CD4+/CD25 + T cells and suppresses experimental autoimmune thyroiditis. J Immunol 170: 5511–5522.CrossRefPubMedGoogle Scholar
  8. 8.
    Kroemer G, Hirsch F, Gonzalez-Garcia A, Martinez C, 1996 Differential involvement of Th1 and, Th2 cytokines in autoimmune diseases. Autoimmunity 24: 25–33.CrossRefPubMedGoogle Scholar
  9. 9.
    Langrish CL, et al, 2005 IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233–240.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Yoshimoto T, Takeda K, Tanaka T, et al, 1998 IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 161: 3400–3407.PubMedGoogle Scholar
  11. 11.
    Kong YC, Morris GP, Brown NK, Yan Y, Flynn JC, David CS, 2009 Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J Autoimmun 33: 239–246.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Gangi E, Vasu C, Cheatem D, Prabhakar BS, 2005 IL-10-producing CD4+CD25+ regulatory T cells play a critical role in granulocyte-macrophage colony-stimulating factor-induced suppression of experimental autoimmune thyroiditis. J Immunol 174: 7006–7013.CrossRefPubMedGoogle Scholar
  13. 13.
    Quaratino S, Badami E, Pang YY, et al, 2004 Degenerate self-reactive human T-cell receptor causes spontaneous autoimmune disease in mice. Nat Med 10: 920–926.CrossRefPubMedGoogle Scholar
  14. 14.
    Ehlers M, Thiel A, Bernecker C, et al, 2012 Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto’s thyroiditis. J Clin Endocrinol Metab 97: 1347–1354.CrossRefPubMedGoogle Scholar
  15. 15.
    Rotondi M, Chiovato L, Romagnani S, Serio M, Romagnani P, 2007 Role of chemokines in endocrine autoimmune diseases. Endocr Rev 28: 492–520.CrossRefPubMedGoogle Scholar
  16. 16.
    Tomer Y, Huber A, 2009 The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 32: 231–239.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Mariotti S, Chiovato L, Vitti P, et al, 1989 Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. Clin Immunol Immunopathol 50(1 Pt 2): S73–84.CrossRefPubMedGoogle Scholar
  18. 18.
    Chiovato L, Bassi P, Santini F, et al, 1993 Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77: 1700–1705.PubMedGoogle Scholar
  19. 19.
    Dayan CM, Daniels GH, 1996 Chronic autoimmune thyroiditis. N Engl J Med 335: 99–107.CrossRefPubMedGoogle Scholar
  20. 20.
    Bartalena L, Tanda ML N, 2009 Clinical practice. Graves’ ophthalmopathy. Engl J Med 360: 994–1001.CrossRefGoogle Scholar
  21. 21.
    Wiersinga WM, 2011 Autoimmunity in Graves’ ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? J Clin Endocrinol Metab 96: 2386–2394.CrossRefPubMedGoogle Scholar
  22. 22.
    Marino M, Chiovato L, Pinchera A 2006 Graves’ disease. In: DeGroot LJ and Jameson JL, Endocrinology, Elsavier, Philadelphia; pp. 1995–2028.Google Scholar
  23. 23.
    Caturegli P, Kimura H, 2010 A nonclassical model of autoimmune hypothyroidism. Thyroid 20: 3–5.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Duntas LH, 2008 Environmental factors and autoimmune thyroiditis. Nat Clin Pract Endocrinol Metab 4: 454–460.CrossRefPubMedGoogle Scholar
  25. 25.
    Tomer Y, 2010 Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20: 715–725.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Brix TH, Kyvik KO, Hegedus L, 2000 A population-based study of chronic autoimmune hypothyroidism in Danish twins. J Clin Endocrinol Metab 85: 536–539.PubMedGoogle Scholar
  27. 27.
    Brix TH, Kyvik KO, Christensen K, Hegedus L, 2001 Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86: 930–934.PubMedGoogle Scholar
  28. 28.
    Kawashima A, Tanigawa K, Akama T, Yoshihara A, Ishii N, Suzuki K, 2011 Innate immune activation and thyroid autoimmunity. J Clin Endocrinol Metab 96: 3661–3671.CrossRefPubMedGoogle Scholar
  29. 29.
    Barbesino G, Chiovato L, 2000 The genetics of Hashimoto’s disease. Endocrinol Metab Clin North Am 29: 357–374.CrossRefPubMedGoogle Scholar
  30. 30.
    Dustin ML, 2008 T-cell activation through immunological synapses and kinapses. Immunol Rev 221: 77–89.CrossRefPubMedGoogle Scholar
  31. 31.
    Ban Y, Davies TF, Greenberg DA, et al, 2004 Arginine at position 74 of the HLA-DRb1 chain is associated with Graves’ disease. Genes Immun 5: 203–208.CrossRefPubMedGoogle Scholar
  32. 32.
    Armitage RJ, Macduff BM, Spriggs MK, Fanslow WC, 1993 Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol 150: 3671–3680.PubMedGoogle Scholar
  33. 33.
    Arpin C, Déchanet J, Van Kooten C, et al, 1995 Generation of memory B cells and plasma cells in vitro. Science 268: 720–722.CrossRefPubMedGoogle Scholar
  34. 34.
    Teft WA, Kirchhof MG, Madrenas J, 2006 A molecular perspective of CTLA-4 function. Annu Rev Immunol 24: 65–97.CrossRefPubMedGoogle Scholar
  35. 35.
    Cloutier JF, Veillette A, 1999 Cooperative inhibition of T-cell antigen receptor signaling by a complex between a kinase and a phosphatase. J Exp Med 189: 111–121.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Davies TF, 2007 Really significant genes for autoimmune thyroid disease do not exist—so how can we predict disease? Thyroid 17: 1027–1029.CrossRefPubMedGoogle Scholar
  37. 37.
    Anderson Ms, 2008 Update in endocrine autoimmunity. J Clin Endocrinol Metab 93: 3663–3670.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Cetani F, Barbesino G, Borsari S, et al, 2001 A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 86: 4747–4752.CrossRefPubMedGoogle Scholar
  39. 39.
    Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF, 1983 Aberrant expression of HLA-DR antigen on thyrocytes in Graves’ disease: relevance for autoimmunity. Lancet 2: 1111–1115.CrossRefPubMedGoogle Scholar
  40. 40.
    Shimojo N, Kohno Y, Yamaguchi K, et al, 1996 Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. Proc Natl Acad Sci USA 93: 11074–11079.CrossRefPubMedGoogle Scholar
  41. 41.
    McLachlan SM, Nagayama Y, Rapoport B, 2005 Insight into Graves’ hyperthyroidism from animal models. Endocr Rev 26: 800–832.CrossRefPubMedGoogle Scholar
  42. 42.
    Nagayama Y, 2005 Animal models of Graves’ hyperthyroidism. Endocr J 52: 385–394.CrossRefPubMedGoogle Scholar
  43. 43.
    Fugazzola L, Cirello V, Beck-Peccoz P, 2012 Microchimerism and endocrine disorders. J Clin Endocrinol Metab 97: 1452–1461.CrossRefPubMedGoogle Scholar
  44. 44.
    Klintschar M, Schwaiger P, Mannweiler S, Regauer S, Kleiber M, 2001 Evidence of fetal microchimerism in Hashimoto’s thyroiditis. J Clin Endocrinol Metab 86: 2494–2498.PubMedGoogle Scholar
  45. 45.
    Ando T, Imaizumi M, Graves PN, Unger P, Davies TF, 2002 Intrathyroidal fetal microchimerism in Graves’ disease. J Clin Endocrinol Metab 87: 3315–3320.PubMedGoogle Scholar
  46. 46.
    Renne C, Ramos Lopez E, Steimle-Grauer SA, et al, 2004 Thyroid fetal male microchimerism in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid infiltrating lymphocytes is more prevalent in Hashimoto’s thyroiditis and Graves’ disease than in follicular adenomas. J Clin Endocrinol Metab 89: 5810–5814.CrossRefPubMedGoogle Scholar
  47. 47.
    Imaizumi M, Pritsker A, Unger P, Davies TF, 2002 Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology 143: 247–253.CrossRefPubMedGoogle Scholar
  48. 48.
    Friedrich N, Schwarz S, Thonack J, John U, Wallaschofski H, Volzke H, 2008 Association between parity and autoimmune thyroiditis in a general female population. Autoimmunity 41: 174–180.CrossRefPubMedGoogle Scholar
  49. 49.
    Walsh JP, Bremner AP, Bulsara MK, et al, 2005 Parity and the risk of autoimmune thyroid disease: a community-based study. J Clin Endocrinol Metab 90: 5309–5312.CrossRefPubMedGoogle Scholar
  50. 50.
    Bulow Pedersen I, Laurberg P, Knudsen N, et al, 2006 Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as trigger of thyroid autoimmunity. Eur J Endocrinol 154: 39–45.CrossRefPubMedGoogle Scholar
  51. 51.
    Sgarbi JA, Kasamatsu TS, Matsumura LK, Maciel RMB, 2010 Parity is not related to autoimmune thyroid disease in a population-based study of Japanese-Brazilians. Thyroid 20: 1151–1156.CrossRefPubMedGoogle Scholar
  52. 52.
    Kondrashova A, Viskari H, Haapala AM, et al, 2007 Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab 93: 729–734.CrossRefPubMedGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2013

Authors and Affiliations

  1. 1.Unit of Internal Medicine and Endocrinology, Fondazione Salvatore Maugeri I.R.C.C.S., Chair of EndocrinologyUniversity of PaviaPaviaItaly

Personalised recommendations